CAXTON CORP

Position in ALXO — Alx Oncology Holdings Inc

CIK 1388551 Princeton, NJ

Position in ALXO

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$41,996

New position

Shares Held

20,946

first reported quarter

Ownership

0.016%

of shares outstanding

% of Portfolio

1.04%

of 13F equity value

Holder Rank

#44

of 68 holders

Holding Since

Mar 2026

1 quarter on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

CAXTON CORP holds $396,089 across 5 Biotechnology names. ALXO ranks #5 (10.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	KYTX	Kyverna Therapeutics, Inc.	18,773	$162,010
2	LXEO	Lexeo Therapeutics, Inc.	13,943	$80,032
3	XFOR	X4 Pharmaceuticals, Inc	15,557	$64,250
4	IKT	Inhibikase Therapeutics, Inc.	28,453	$47,801
5	ALXO	Alx Oncology Holdings Inc This page	20,946	$41,996

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$41,996	20,946	—	Shares	Sole	2026-05-14
No filing history on record for this holder in this stock.